$2.68
+25%Owens & Minor, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States and internationally. It operates through two segments, Global Solutions and Global Products. The Global Solutions segment offers a portfolio of products and services to healthcare providers and manufacturers. Its portfolio of medical and surgical supplies includes branded products and its proprietary products. This segment also offers services to healthcare providers, which include supplier management, analytics, inventory management, and clinical supply management; and various programs to provide logistics and marketing solutions to its suppliers. The Global Products segment manufactures and sources medical surgical products for the prevention of healthcare-associated infections across the acute and alternate site channels. This segments products portfolio includes sterilization wraps, surgical drapes and gowns, facial protection products, protective apparel, medical exam gloves, custom and minor procedure kits, and other medical products. It provides its products and services to multi-facility networks of healthcare providers, independent hospitals, surgery centers, physicians' practices, and networks of hospitals directly, as well as indirectly through third-party distributors. The company was founded in 1882 and is headquartered in Richmond, Virginia.
Director of Media Relations
Executive Vice President & Chief Executive Officer of Patient Direct Segment
Compensation
$1,292,011
Executive Vice President & Chief Human Resources Officer
Executive Vice President & Chief Information Officer
Executive Vice President and Chief Executive Officer of Products & Healthcare Services Segment
Compensation
$1,343,781
Executive Vice President, Chief Financial Officer & Corporate Treasurer
Compensation
$764,562
Executive Vice President, General Counsel & Corporate Secretary
Compensation
$883,541
President, Chief Executive Officer & Director
Compensation
$2,904,579
Senior Vice President, Corporate Controller & Chief Accounting Officer
Compensation
$261,659
During the last 12 months, insiders have purchased $8.10M and sold $23K worth of OMI shares, resulting in $8.08M of net buying activity.
0
0.00
0
0.00
+0
+$0
0
0.00
0
0.00
+0
+$0
0
0.00
4.3K
23.03K
-23K
-$23K
1.5M
8.10M
0
0.00
+8.1M
+$8.10M
Coliseum Capital Management, Llc
10 Percent Owner
$8.10M
Leon Jonathan A
Officer: Evp & Cfo
$23K
Strong bullish signal with $8.08M net buying. Insiders are aggressively accumulating shares, suggesting significant confidence in future prospects.
Exceptional buy/sell ratio. Buying dramatically outweighs selling—one of the strongest possible insider signals.
1 insider buyers and 1 sellers. Equal participation suggests mixed or neutral insider views.
OMI - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
DEF 14A DEF 14A 2025 N/A | April 04, 2025 | May 15, 2025 | 2025 | |
DEF 14A DEF 14A 2024 N/A | March 27, 2024 | May 09, 2024 | 2024 | |
DEF 14A DEF 14A N/A | March 29, 2023 | March 29, 2023 | ||
DEF 14A DEF 14A 2022 N/A | March 17, 2022 | April 29, 2022 | 2022 | |
DEF 14A DEF 14A 2021 N/A | March 17, 2021 | April 29, 2021 | 2021 | |
DEF 14A DEF 14A 2020 N/A | March 19, 2020 | May 01, 2020 | 2020 | |
DEF 14A DEF 14A 2019 N/A | March 28, 2019 | May 10, 2019 | 2019 | |
DEF 14A DEF 14A 2018 N/A | March 26, 2018 | May 08, 2018 | 2018 | |
DEF 14A DEF 14A 2017 N/A | March 22, 2017 | May 05, 2017 | 2017 | |
DEF 14A DEF 14A 2016 N/A | March 23, 2016 | May 06, 2016 | 2016 |
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.